Obama education chief: Trump sounding ‘dog whistle’ in bashing 1619 Project

Trump has railed in recent weeks against “critical race theory” and the 1619 Project by The New York Times, which centers the telling of U.S. history around the effects of slavery and contributions of Black individuals and now offers curriculum for schools. The president has also been advocating for “patriotic education” and promising to create a new federal commission to advance that objective.

Last week, the president said he would establish a new “1776 commission” by executive action, in order to encourage educators to teach children about “the miracle of American history” and make plans to honor the 250th anniversary of America’s founding.

The federal government is barred by law from dictating curriculum, however.

Chicago Public Schools CEO Janice Jackson said her school district was one of the first systems to adopt the 1619 Project in its curriculum. As a former history teacher, Jackson said the most “powerful” part of

Read More

Disrupter in chief Sharonica L. Hardin-Bartley is 2020 Stellar Performer in Education | Local News



University City Schools Superintendent Sharonica L. Hardin-Bartley

University City Schools Superintendent Sharonica L. Hardin-Bartley is the St. Louis American Foundation’s 2020 Stellar Performer.


University City Schools Superintendent Sharonica L. Hardin-Bartley is a status-quo disrupter.

“The bravery she shows is unparalleled,” said Christina Groves, middle-school teacher and parent in the district. “It is very clear to those of us who care about the education of all children that the way we do school is not sustainable; it is not helping students grow, and it’s actually designed in many ways to keep the status quo. And Dr. Hardin-Bartley is not at all afraid to disrupt that.”

After Hardin-Bartley became superintendent in 2016, she led the district in drafting a strategic plan that aims to “humanize, personalize and problematize” the learning experience for their students. When she served on the Ferguson Commission’s Youth at the Center workgroup, Hardin-Bartley helped to write the commission’s recommendations for schools, specifically for addressing trauma.

Read More

Intel (INTC) Names Saf Yeboah-Amankwah As SVP And Chief Strategy Officer

  • Intel Corporation (NASDAQ: INTC) recently announced it has appointed Safroadu (Saf) Yeboah-Amankwah as SVP and chief strategy officer

Intel Corporation (NASDAQ: INTC) recently announced it has appointed Safroadu (Saf) Yeboah-Amankwah as SVP and chief strategy officer, effective November 1. Yeboah-Amankwah is going to be responsible for the Global Strategy Office, including Intel Capital and will work with the executive team on developing and driving growth-oriented strategies. And Yeboah-Amankwah will report to CEO Bob Swan.

Yeboah-Amankwah is joining Intel from McKinsey & Company where he was most recently a senior partner and global head of the Transformation Practice for the Telecom, Media and Technology (TMT) practice, based in Washington, D.C. And he is also the global lead of Client Capabilities for the TMT practice. Previously he worked as managing partner for South Africa and head of McKinsey’s TMT and Digital practice for Africa, among other roles.

Prior to starting his career,

Read More

DVIDS – News – NUWC Division Newport chief technology officer wins National Defense Industrial Association Bronze Medal


NEWPORT, R.I. — Dr. Jason Gomez, Naval Undersea Warfare Center (NUWC) Division Newport’s chief technology officer, was recently selected as the 2020 National Defense Industrial Association Bronze Medal winner, an annual award that recognizes outstanding individual achievements in science or engineering in the field of undersea warfare.

Gomez, a resident of East Greenwich, Rhode Island, began his 28-year career at Division Newport in 1992 as a mechanical engineer. While working with the fleet, he managed the Contender Program, a $290 million program for the Strategic Capabilities Office, which will transition into the heavyweight torpedo program of record to deliver both long-range anti-submarine warfare and anti-surface warfare capabilities. He managed the Defense Advanced Research Projects Agency Underwater Express program and successfully developed the world’s fastest electric underwater vehicle and the first controlled supercavitating vehicle in the U.S. This success led to the Blue Wolf program, where his work enabled significant

Read More

GoldMining Announces Appointment of Alastair Still as Executive VP, Chief Development Officer

VANCOUVER, BC, Sept. 21, 2020 /PRNewswire/ – GoldMining Inc. (the “Company” or “GoldMining”) (TSX: GOLD) (OTCQX: GLDLF) is pleased to announce the appointment of Alastair Still as Executive Vice President, Chief Development Officer of GoldMining and as Director of Technical Services of its subsidiary, Gold Royalty Corp. (“Gold Royalty”) effective October 1, 2020.

Garnet Dawson, CEO of GoldMining, commented: “With over 25 years industry experience including leadership roles with major gold miners, most recently as Director, Corporate Development with Newmont, Alastair will have an immediate impact at GoldMining, and we are excited to welcome him to the team. Alastair’s diverse background with Agnico Eagle, Kinross Gold, Placer Dome, Goldcorp and Newmont in mine operations, project development and corporate development is the perfect mix of skills and experience as we seek to execute our two-pronged strategy of expanding our property portfolio of resource stage gold projects through

Read More

Medly Pharmacy Expands Executive Team With Appointment of Chief Technology Officer and Chief Financial Officer

BROOKLYN, N.Y., Sept. 9, 2020  /PRNewswire/ — Medly Pharmacy, a full-service, digital pharmacy that offers free same-day prescription delivery, has expanded its executive team by welcoming two new members to the company’s C-suite. Robert “Rob” Horowitz will join the company as Chief Financial Officer (CFO) and Prasad Pola will join as Chief Technology Officer (CTO).

Medly Logo (PRNewsfoto/Medly Pharmacy)

The expansion of the executive team coincides with Medly’s plan to expand its platform nationally, following its Series B funding round. With a deep understanding of how to effectively manage and strategize a company’s financials, Mr. Horowitz will be responsible for focusing on Medly’s growth into additional markets. Mr. Pola, working from the same blueprint, will be examining all product technologies for optimization, steering Medly toward what is most efficient for the company, and its existing and new customer base.

“We are very pleased to welcome both

Read More

Highland Therapeutics Announces New Chief Commercial Officer and Appointment of Chief Scientific Officer – Press Release

TORONTO–(Business Wire)–Highland Therapeutics Inc. (“Highland”) today announced two executive appointments at its wholly owned subsidiaries. Mr. Danny Villeneuve has assumed the role of Executive Vice President and Chief Commercial Officer and Dr. Bev Incledon has been promoted to the role of Executive Vice President and Chief Scientific Officer at Ironshore Pharmaceuticals Inc. and Ironshore Pharmaceuticals & Development, Inc., respectively. Both appointments are effective immediately.

“I am delighted to welcome Danny to the Ironshore family of companies and congratulate both him and Bev on the appointments,” said David Lickrish, Highland’s Chairman & Chief Executive Officer. “Danny brings a wealth of experience to Ironshore, gained from a 25-year career in the pharmaceutical industry, including 13 years directly in ADHD. His leadership skills and deep expertise in all facets of commercial operations, including sales, marketing and market access will be terrific assets to leverage as we seek to improve outcomes for patients with

Read More

Mars Appoints Dr. Maria Velissariou as Global Corporate R&D Vice President and Chief Science Officer

Dr. Velissariou was with the Institute of Food Technologists before joining Mars and serves on the board of directors of the Chicago Council for Science and Technology.  

MCLEAN, Va., Sept. 10, 2020 /PRNewswire/ — Mars, Incorporated announced today the hiring of Dr. Maria Velissariou as the new Global Corporate Research & Development (R&D) Vice President and Chief Science Officer. Dr. Velissariou joins Mars on Sept. 13 and will lead Mars’ enterprise-wide approach to Quality and Food Safety, Scientific & Regulatory Affairs and deliver Mars’ R&D strategy in partnership with its business segments. Dr. Velissariou will report into Jean-Christophe Flatin, President of Innovation, Science, Technology & Mars Edge and will partner with the existing Mars Chief Science Officer and Vice President of Corporate R&D, David Crean, as a transition to his retirement in April 2021.

Most recently, Dr. Velissariou was the Chief Science and Technology Officer at the Institute of Food

Read More

Mars Welcomes Dr. Maria Velissariou as New Global Corporate R&D Vice President and Chief Science Officer | News

MCLEAN, Va., Sept. 10, 2020 /PRNewswire/ — Mars, Incorporated announced today the hiring of Dr. Maria Velissariou as the new Global Corporate Research & Development (R&D) Vice President and Chief Science Officer. Dr. Velissariou joins Mars on Sept. 13 and will lead Mars’ enterprise-wide approach to Quality and Food Safety, Scientific & Regulatory Affairs and deliver Mars’ R&D strategy in partnership with its business segments. Dr. Velissariou will report into Jean-Christophe Flatin, President of Innovation, Science, Technology & Mars Edge and will partner with the existing Mars Chief Science Officer and Vice President of Corporate R&D, David Crean, as a transition to his retirement in April 2021.

Most recently, Dr. Velissariou was the Chief Science and Technology Officer at the Institute of Food Technologists (IFT), where she oversaw science, technology, and policy strategies, advocated for the science of food, and partnered with stakeholders across industry, academia,

Read More

Element Science Names Zubin J. Eapen, MD as Chief Medical Officer

Experienced Cardiologist Brings Expertise in Launching and Scaling Innovative Models of Care

Element Science, an innovative health technology company pioneering a next-generation digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, announced today that it has appointed Zubin J. Eapen, MD, MHS, FACC, FAHA, as Chief Medical Officer. Dr. Eapen, an experienced health system leader who has launched and scaled innovative models of care and overseen numerous clinical trials, will help advance the Company’s initial product, the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD).

The Jewel P-WCD is the first product built on the novel Jewel platform, which is designed to help patients reduce their need for hospitalization through diagnostic, therapeutic, and connected capabilities. The Jewel platform is an unobtrusive, low-profile personal defibrillator designed to detect and treat life-threatening arrhythmias in patients with an elevated temporary risk of Sudden Cardiac Death (SCD), a condition more than 500,000 patients

Read More